The claimed invention was made subject to a joint research agreement between Cardiac Pacemakers, Inc. and Remon Medical Technologies Ltd.
The present invention relates to sensors used in combination with a cardiac function management device such as a heart pacemaker or defibrillator to monitor and control the rhythm of the heart. The present invention more particularly relates to sensors used to detect heart sounds and methods of modifying therapy based on these heart sounds.
Cardiac function management systems are used to treat heart arrhythmias. Pacemaker systems are commonly implanted in patients to treat bradycardia (i.e., abnormally slow heart rate). A pacemaker system includes an implantable pulse generator and leads, which form the electrical connection between the implantable pulse generator and the heart. An implantable cardioverter defibrillator (“ICD”) is used to treat tachycardia (i.e., abnormally rapid heart rate). An ICD also includes a pulse generator and leads that deliver electrical energy to the heart. These systems are also useful in the treatment of heart failure, which is often caused by bundle branch block that can disrupt synchrony between the right and left ventricles. For example, cardiac resynchronization therapy (“CRT”) (also commonly referred to as biventricular pacing) is an emerging treatment for heart failure, which involves stimulation of both the right and the left ventricles to increase hemodynamic efficiency and cardiac output.
The beating heart produces a series of auditory vibrations (i.e., heart sounds) that can be characterized by intensity, frequency, quality, and timing with respect to the cardiac cycle. Two of the normal heart sounds, commonly known as the S1 and S2 sounds, relate to closing of various heart valves. Specifically, the S1 sound is generated by the closing of the mitral and tricuspid valves and thus generally correlates to the onset of ventricular systole, and the S2 sound is generated by the closing of the pulmonary and aortic valves and thus generally correlates to the onset of ventricular diastole. These sounds may also indicate problems or abnormalities in the pumping process, such as for example a murmur or mitral regurgitation. There is thus a need for a cardiac rhythm management device that includes a sensor for sensing heart sounds.
The present invention, according to one embodiment, is an implantable medical device (IMD) including a pulse generator having a compartment, which defines an isolated cavity bounded by a back wall. A compartment diaphragm is disposed over and encloses the cavity. An acoustic sensor adapted to sense chest sounds and generate a signal is disposed between the diaphragm and the back wall. A control circuit disposed within the pulse generator is operatively coupled to the acoustic sensor and is adapted to receive the signal.
According to another embodiment, the present invention is an implantable medical device (IMD) includinga pulse generator; a sensor module located remotely from the pulse generator, the sensor module defining a compartment having a compartment diaphragm, an acoustic sensor adapted to sense chest sounds and generate a signal, the acoustic sensor located in the compartment, and a control circuit disposed within the pulse generator, the circuit operatively coupled to the acoustic sensor and adapted to receive the signal.
The present invention, according to yet another embodiment, is a cardiac function management (CFM) system for effecting operation of a human heart. The system includes a pulse generator having a compartment, the compartment defining an isolated cavity bounded by a back wall. A compartment diaphragm is disposed over and enclosing the cavity. An acoustic sensor adapted to sense chest sounds and generate a first signal is disposed between the compartment diaphragm and the back wall. A cardiac lead has an electrode and is adapted to sense electrical activity of the heart. A control circuit is disposed within the pulse generator and is operatively coupled to the acoustic sensor and the cardiac lead.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
The heart 16 includes a right atrium 22, a right ventricle (RV) 24, and a pulmonary artery 26. A tricuspid valve 28 is located between and controls the flow of blood from the right atrium 22 and the right ventricle 24. A pulmonic valve 30 is located between and controls the flow of blood from the right ventricle 24 to the pulmonary artery 26. The heart 16 also includes a left atrium 32, a left ventricle (LV) 34, and an aorta 36. A mitral valve 38 is located between and controls the flow of blood from the left atrium 32 to the left ventricle 34. A aortic valve 40 is located between and controls the flow of blood from the left ventricle 34 to the aorta 36. In one embodiment, the CFM system 10 includes a plurality of leads 14. For example, it may include a first lead 14 in communication with the left ventricle 34 and a second lead in communication with the right ventricle 24.
The heart sound S1 is generated when the mitral valve 38 and the tricuspid valve 28 close. The S1 sound is referred to as the “lub” part of the “lub-dub” rhythm of the heart. The heart sound S2 is generated when the pulmonic valve 30 and the aortic valve 40 close and is referred to as the “dub” sound. The S3 heart sound is known to be a ventricular diastolic filling sound often indicative of certain pathological conditions including heart failure, and the S4 heart sound is known to be a ventricular diastolic filling sound resulting from atrial contraction and is also usually indicative of pathological conditions. The phrase “heart sound,” as used herein refers to any sound made by the heart during operation, including any of S1, S2, S3, S4, or any components thereof. Other notable heart sounds include that of mitral regurgitation (MR). The phrase “chest sound,” as used herein includes heart sounds as well as lung sounds and any other sounds that may be present in a patient's chest cavity. Common lung sounds of interest include coughs, rales and wheezes. Other chest sounds may include, for example, snoring and talking.
In the embodiment shown in
As shown in
In the embodiment shown in
The acoustic sensor 62 is adapted to sense broadband chest sounds, which may include for example heart and lung sounds such as S2 splitting, mitral regurgitation, coughs, rales, and wheezes. Other chest sounds, which may be detected by the acoustic sensor 62 include Gallop sounds, snoring and a patient's voice. The acoustic sensor 62 is electrically connected to the circuitry 52 by one or more feedthroughs 64. The sensor 62 may have, for example, a broadband acoustic range of from about 10 to about 20,000 Hz. In one embodiment, the range of the sensor 62 is from about 100 to about 5,000 Hz, and, in yet another embodiment, the range is from about 100 to about 3,000 Hz.
The acoustic sensor 62 can be comprised of any of a variety of microphones known in the art. Exemplary microphones include piezoelectric, piezoresistive, and capacitive-type microphones. The piezoelectric microphone may be made from any piezoelectric material, including piezocomposites, piezoceramics, piezoplastics and the like. The sensor 62 may, for example, be comprised of a piezoelectric film, such as polyvinylidine fluoride (PVDF), which takes the form of a thin plastic polymer sheet and may have a thin electrically conductive nickel copper alloy deposited on each side. The sensor 62 acts as a strain gage that generates an electrical signal when the compartment diaphragm 58 vibrates in response to a heart or lung sound.
In one embodiment, the acoustic sensor 62 is a micro-electrical mechanical system (MEMS) device. One such exemplary device is the SiSonic MEMS microphone available from Knowles Acoustics, Inc. (www.knowlesacoustics.com) of Itasca, Ill. A MEMS microphone is fabricated from a silicon chip using standard semiconductor processing techniques. Such a microphone may include a diaphragm and a backplate fabricated from a silicon wafer. In one embodiment, the thickness of the sensor 62 is from about 0.01 to about 2 mm. In another embodiment, the thickness of the sensor 62 is less than about 0.5 mm. The acoustic sensor 62 may have a width dimension and a length dimension each between about 1 and about 2 mm.
As shown in
In one embodiment, the acoustic sensor 62 is an accelerometer, including, for example, a piezoelectric crystal accelerometer sensor of the type used by pacemakers to sense the level of activity of the patient. Use of such an accelerometer for detecting heart sounds is described in more detail, for example, in U.S. Publication 2005/0137490 and U.S. Publication 2005/0102001, both of which are hereby incorporated by reference. In another exemplary embodiment, the IMD 10 includes both an accelerometer and a piezoelectric sensor. In this embodiment, the accelerometer is typically located inside the hermetic housing and is generally most effective at sensing lower frequencies, whereas the sensor is in a cavity located behind a diaphragm and is optimized for detecting frequencies above that detected by the accelerometer.
The compartment diaphragm 58 and the compartment 56 can be any shape, including circular, oval, rectangular, or square. In the embodiment shown in
In one embodiment, the acoustic sensor 62 of
Such a configuration as is shown in
Several techniques for identifying a specified chest sounds may be employed, including, for example, analyzing the signal from the acoustic sensor 62 to identify the presence of a signal exceeding a certain amplitude within a certain frequency range and within a specified portion of the cardiac cycle. In one embodiment, a specified chest sound is identified by comparing the signal to an acoustic template representing a “normal” condition or to sounds previously recorded for that particular patient. These previously recorded sounds could, for example, be stored during an examination by a physician, after the physician confirms acceptable heart function. In one embodiment, the ECG information is used to further assist in detecting a specified heart sound. The ECG information, for example, may be used to “window” a certain portion of the acoustic data, based on knowledge of a skilled artisan relating to the location in the cardiac cycle during which a specified sound is likely to occur. Exemplary techniques for identifying a specified heart sound and for correlating the acoustic data to a certain location in the cardiac cycle is disclosed in commonly-assigned U.S. Publication 2004/0106961, which is hereby incorporated by reference.
In one embodiment, the circuitry 52 further includes a logbook feature. In this embodiment, for example, the controller 78 may operate to store a predetermined time period of data in a specified area of the memory 80 periodically, or it may operate to store a specified time period of data only upon detection of an abnormal condition. This feature then allows a user to access this stored data at a later time for additional analysis.
In one embodiment, the system further includes an external device 84, which is operatively coupled to the circuitry 52 by, for example, a wireless RF communication link. The external device 84 may, for example, be an external programmer adapted for use with the implanted medical device 10. This external device 84 is, in turn, coupled to a remote system 86. The external device 84 and remote system 86 may, for example, be coupled by a telephone line, electrical or optical cable, RF interface, satellite link, local area network or wide area network. The remote system 86 allows a user (e.g., a physician) located at a remote location to obtain data relating to the heart sounds and to conduct or aid in the diagnosis of a patient based on such data. In one embodiment, the remote system 86 includes an advanced patient management system, such as is disclosed in U.S. Publication 2004/0122484, which is hereby incorporated by reference in its entirety.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
Number | Name | Date | Kind |
---|---|---|---|
2967957 | Massa | Jan 1961 | A |
3568661 | Franklin | Mar 1971 | A |
3676720 | Libby et al. | Jul 1972 | A |
3757770 | Brayshaw et al. | Sep 1973 | A |
3792204 | Murayama et al. | Feb 1974 | A |
3798473 | Murayama et al. | Mar 1974 | A |
3832580 | Yamamuro et al. | Aug 1974 | A |
3894198 | Murayama et al. | Jul 1975 | A |
3940637 | Ohigashi et al. | Feb 1976 | A |
3978353 | Kinoshita | Aug 1976 | A |
4008408 | Kodama | Feb 1977 | A |
4051455 | Fowler | Sep 1977 | A |
4056742 | Tibbetts | Nov 1977 | A |
4064375 | Russell et al. | Dec 1977 | A |
4096756 | Alphonse | Jun 1978 | A |
4127110 | Bullara | Nov 1978 | A |
4170742 | Itagaki et al. | Oct 1979 | A |
4181864 | Etzold | Jan 1980 | A |
4227407 | Drost | Oct 1980 | A |
4281484 | Massa | Aug 1981 | A |
4431873 | Dunn et al. | Feb 1984 | A |
4433400 | De Reggi et al. | Feb 1984 | A |
4456850 | Inoue et al. | Jun 1984 | A |
4481950 | Duggan | Nov 1984 | A |
4517665 | De Reggi et al. | May 1985 | A |
4519401 | Ko et al. | May 1985 | A |
4541431 | Ibrahim et al. | Sep 1985 | A |
4558249 | Lerch et al. | Dec 1985 | A |
4580074 | Gilman | Apr 1986 | A |
4593703 | Cosman | Jun 1986 | A |
4600855 | Strachan | Jul 1986 | A |
4642508 | Suzuki et al. | Feb 1987 | A |
4653036 | Harris et al. | Mar 1987 | A |
4653508 | Cosman | Mar 1987 | A |
4660568 | Cosman | Apr 1987 | A |
4672976 | Kroll | Jun 1987 | A |
4676255 | Cosman | Jun 1987 | A |
4677337 | Kleinschmidt et al. | Jun 1987 | A |
4781715 | Wurzel | Nov 1988 | A |
4793825 | Benjamin et al. | Dec 1988 | A |
4835435 | Yeung et al. | May 1989 | A |
4846191 | Brockway et al. | Jul 1989 | A |
4911172 | Bui et al. | Mar 1990 | A |
4958100 | Crawley et al. | Sep 1990 | A |
5012815 | Bennett, Jr. et al. | May 1991 | A |
5024224 | Engebretson | Jun 1991 | A |
5088576 | Potthoff et al. | Feb 1992 | A |
5113859 | Funke | May 1992 | A |
5160870 | Carson et al. | Nov 1992 | A |
5178153 | Einzig | Jan 1993 | A |
5283397 | Pavlovic | Feb 1994 | A |
5289821 | Swartz | Mar 1994 | A |
5300875 | Tuttle | Apr 1994 | A |
5314457 | Jeutter et al. | May 1994 | A |
5339290 | Greenstein | Aug 1994 | A |
5367500 | Ng | Nov 1994 | A |
5381067 | Greenstein et al. | Jan 1995 | A |
5381386 | Lum et al. | Jan 1995 | A |
5410587 | Grunwell | Apr 1995 | A |
5411551 | Winston et al. | May 1995 | A |
5423334 | Jordan | Jun 1995 | A |
5438553 | Wilson et al. | Aug 1995 | A |
5476488 | Morgan et al. | Dec 1995 | A |
5483501 | Park et al. | Jan 1996 | A |
5488954 | Sleva et al. | Feb 1996 | A |
5495137 | Park et al. | Feb 1996 | A |
5554177 | Kieval et al. | Sep 1996 | A |
5562714 | Grevious | Oct 1996 | A |
5571152 | Chen et al. | Nov 1996 | A |
5628782 | Myers et al. | May 1997 | A |
5679026 | Fain et al. | Oct 1997 | A |
5704352 | Tremblay et al. | Jan 1998 | A |
5733313 | Barreras, Sr. et al. | Mar 1998 | A |
5735887 | Barreras, Sr. et al. | Apr 1998 | A |
5741316 | Chen et al. | Apr 1998 | A |
5749909 | Schroeppel et al. | May 1998 | A |
5757104 | Getman et al. | May 1998 | A |
5792195 | Carlson et al. | Aug 1998 | A |
5807258 | Cimochowski et al. | Sep 1998 | A |
5825117 | Ossmann et al. | Oct 1998 | A |
5832924 | Archibald et al. | Nov 1998 | A |
5833603 | Kovacs et al. | Nov 1998 | A |
5843135 | Weijand et al. | Dec 1998 | A |
5873835 | Hastings et al. | Feb 1999 | A |
5879283 | Adams et al. | Mar 1999 | A |
5935081 | Kadhiresan | Aug 1999 | A |
5956292 | Bernstein | Sep 1999 | A |
5957950 | Mockros et al. | Sep 1999 | A |
5967986 | Cimochowski et al. | Oct 1999 | A |
6044298 | Salo et al. | Mar 2000 | A |
6053873 | Govari et al. | Apr 2000 | A |
6058329 | Salo et al. | May 2000 | A |
6068589 | Neukermans | May 2000 | A |
6082367 | Greeninger et al. | Jul 2000 | A |
6140740 | Porat et al. | Oct 2000 | A |
6185452 | Schulman et al. | Feb 2001 | B1 |
6223081 | Kerver | Apr 2001 | B1 |
6409675 | Turcott | Jun 2002 | B1 |
6475170 | Doron et al. | Nov 2002 | B1 |
6477406 | Turcott | Nov 2002 | B1 |
6480733 | Turcott | Nov 2002 | B1 |
6486588 | Doron et al. | Nov 2002 | B2 |
6527729 | Turcott | Mar 2003 | B1 |
6537200 | Leysieffer et al. | Mar 2003 | B2 |
6554761 | Puria et al. | Apr 2003 | B1 |
6575894 | Leysieffer et al. | Jun 2003 | B2 |
6600949 | Turcott | Jul 2003 | B1 |
6628989 | Penner et al. | Sep 2003 | B1 |
6629922 | Puria et al. | Oct 2003 | B1 |
6643548 | Mai et al. | Nov 2003 | B1 |
6645145 | Dreschel et al. | Nov 2003 | B1 |
6654638 | Sweeney | Nov 2003 | B1 |
6671550 | Iaizzo et al. | Dec 2003 | B2 |
6697674 | Leysieffer | Feb 2004 | B2 |
6740076 | Hoben et al. | May 2004 | B2 |
6741714 | Jensen | May 2004 | B2 |
6763722 | Fjield et al. | Jul 2004 | B2 |
6764446 | Wolinsky et al. | Jul 2004 | B2 |
7016739 | Bange et al. | Mar 2006 | B2 |
7024248 | Penner et al. | Apr 2006 | B2 |
7035684 | Lee | Apr 2006 | B2 |
7107103 | Schulman et al. | Sep 2006 | B2 |
7220232 | Suorsa et al. | May 2007 | B2 |
7228175 | Jain et al. | Jun 2007 | B2 |
7236821 | Cates | Jun 2007 | B2 |
7283874 | Penner | Oct 2007 | B2 |
7335169 | Thompson et al. | Feb 2008 | B2 |
20020027400 | Toda | Mar 2002 | A1 |
20020036446 | Toda et al. | Mar 2002 | A1 |
20020151938 | Corbucci | Oct 2002 | A1 |
20020177782 | Penner | Nov 2002 | A1 |
20030055461 | Girouard et al. | Mar 2003 | A1 |
20030204165 | Houben et al. | Oct 2003 | A1 |
20040015104 | Goldberger | Jan 2004 | A1 |
20040103906 | Schulman et al. | Jun 2004 | A1 |
20040106954 | Whitehurst et al. | Jun 2004 | A1 |
20040106960 | Siejko et al. | Jun 2004 | A1 |
20040106961 | Siejko et al. | Jun 2004 | A1 |
20040122315 | Krill | Jun 2004 | A1 |
20040122484 | Hatlestad et al. | Jun 2004 | A1 |
20040127792 | Siejko et al. | Jul 2004 | A1 |
20040138572 | Thiagarajan | Jul 2004 | A1 |
20040147969 | Mann et al. | Jul 2004 | A1 |
20040167416 | Lee | Aug 2004 | A1 |
20040172083 | Penner | Sep 2004 | A1 |
20040204744 | Penner et al. | Oct 2004 | A1 |
20040230249 | Haefner | Nov 2004 | A1 |
20050102001 | Maile et al. | May 2005 | A1 |
20050131472 | Ding et al. | Jun 2005 | A1 |
20050137490 | Scheiner et al. | Jun 2005 | A1 |
20050148896 | Siejko et al. | Jul 2005 | A1 |
20050149136 | Siejko et al. | Jul 2005 | A1 |
20050149138 | Min et al. | Jul 2005 | A1 |
20060009818 | Von Arx et al. | Jan 2006 | A1 |
20060082259 | Schlenke | Apr 2006 | A1 |
20060142819 | Penner et al. | Jun 2006 | A1 |
20060149329 | Penner | Jul 2006 | A1 |
20080021289 | Zhang et al. | Jan 2008 | A1 |
20080021509 | Mi et al. | Jan 2008 | A1 |
20080021510 | Mi et al. | Jan 2008 | A1 |
Number | Date | Country |
---|---|---|
0798016 | Oct 1997 | EP |
0897690 | Feb 1999 | EP |
1151719 | Nov 2001 | EP |
WO 8303345 | Oct 1983 | WO |
WO 9701986 | Jan 1997 | WO |
WO 9733513 | Sep 1997 | WO |
9735636 | Oct 1997 | WO |
WO 9747236 | Dec 1997 | WO |
WO 9826716 | Jun 1998 | WO |
WO 9829030 | Jul 1998 | WO |
WO 9926530 | Jun 1999 | WO |
WO 9959460 | Nov 1999 | WO |
WO 0016686 | Mar 2000 | WO |
WO 03068047 | Aug 2003 | WO |
2004091719 | Oct 2004 | WO |
WO 2006069215 | Jun 2006 | WO |
Number | Date | Country | |
---|---|---|---|
20070049977 A1 | Mar 2007 | US |